Altasciences’ preclinical experts have developed an extensive resource library to guide you through safety assessments for both small molecules and biologics.

Webinars:

Downsized Miniature Swine: A New Spin on the Oldest Model

Discover the increasing body of evidence that supports the use of miniature swine as a viable option for your small molecule and biologics studies.

Navigating the Challenges of Early Drug Development—How to Avoid Common Pitfalls

What you need to know before starting a drug development program—with supporting case studies.

Case Studies Adversity Level Determination in Nonclinical Toxicity Studies

How to interpret data on toxicity studies to classify adverse versus non-adverse effects. 

The Altascientist—A Scientific Journal:

A Changing Paradigm for Non-Rodent Species in Nonclinical Safety Studies

How, with the increase of historical data and wider regulatory acceptance, the miniature swine model can support a variety of research areas.

Safety Pharmacology Guidelines and Practices—a Review

How to save time and reduce the number of research models on study, all while ensuring the quality of your data.

Navigating the IND Submission Process

Tips for planning your preclinical assessments in support of a successful regulatory submission—including when to initiate discussions with a CRO. 

eBook:

Nonclinical Assessment Planning Guide

Our guide will help you navigate the regulatory process and identify key milestones to get your drug to the people who need it, faster.

Scratching the Surface of Dermal Testing

Learn more about our nonclinical dermal testing solutions, including the applications of miniature swine in this therapeutic area.

Proactive Drug Development:

We can accelerate the development of your molecules by up to 40%, from lead identification to clinical POC.